Pharmacy Report Archives - Page 43 of 148 - Becker's Hospital Review

Cancer drug shortages 'a moving target' | A post-Ozempic surgery trend | Mail-order pharmacies hurt employers: Report | CVS to debut new app | Pharmacy owners sentenced in $18M fraud case

June 26, 2024 BHR Newsletter 1. New drug cuts cardiovascular events, death by 36% Full story 2. Cancer drug shortages 'a moving target,' cancer centers say Full story 3. GLP-1s are reshaping plastic surgery patient demands Full story 4. The…

1st generic GLP-1 arrives | Older adults overuse aspirin: Study | Ozempic label might grow by January | Intermountain expands pharmacy center | Top 10 cities to retire: US News

June 25, 2024 BHR Newsletter 1. Older adults still taking aspirin for heart health despite push to stop Full story 2. Teva launches first generic GLP-1 Full story 3. Intermountain expands pharmacy fulfillment center Full story 4. Documenting and coding…

Walgreens seeks provider status for pharmacists | Pebbles in 3 pharmacy leaders' shoes | How Houston Methodist pharmacists use Alexa | Eli Lilly sues over phony Mounjaro sales | Construction halts on $1.5B hospital

June 24, 2024 BHR Newsletter 1. AdventHealth launches 1st-of-kind cancer vaccine trial Full story 2. Walgreens pursues provider status for pharmacists Full story 3. Eli Lilly hits phony drugmakers with 6 more lawsuits Full story 4. Some CNOs are gaining…

Where Mark Cuban's drug savings fall short | 5 new drug shortages | 10 systems seek pharmacy leaders | UW Health's answer to limited pharmacy hours | GLP-1s best for children's weight loss: Study

June 20, 2024 BHR Newsletter 1. 5 drugs now in shortage Full story 2. Insured patients often save less with Mark Cuban's drug company: Study Full story 3. GLP-1s effective at pediatric weight management, BMI reduction Full story 4. How…

2 deaths pause 3 drug trials | Top 15 schools by NAPLEX pass rates | Reflections from a 24-year-old CEO | 1st adult vaccine for bacterial pneumonia approved | A strategic C-suite entry

June 19, 2024 BHR Newsletter 1. Cancer therapy trials paused after 2 deaths Full story 2. A strategic transition into the C-suite Full story 3. FDA approves 1st adult vaccine for bacterial pneumonia Full story 4. AI is accelerating clinical research…

Physician execs: GLP-1s dull alcohol cravings | 340B spending up 19% | CivicaScript drug saved 1 payer $3M | ADHD med shortage could get worse | The 'messy state' of weight loss drugs

June 18, 2024 BHR Newsletter 1. Are GLP-1s curbing alcohol, gambling addictions? Full story 2. Digital health executives' arrests could disrupt ADHD treatment, CDC says Full story 3. 340B drug program spending up 19% + 6 other notes Full story…

40% fewer people need statins: Study | Mark Cuban: Pharma is 'easiest industry' to disrupt | DSCSA enforcement delayed for small pharmacies | Heat waves + meds: Health risks to know | 2 strategies for a $9 trillion workforce issue

June 17, 2024 BHR Newsletter 1. Mark Cuban: Pharma has been 'easiest industry' to disrupt Full story 2. New heart disease risk tool finds 40% fewer people need statins: Study Full story 3. FDA again delays Drug Supply Chain Security…

Houston Methodist pharmacies employ Alexa | Tech glitches cause near misses | SCOTUS upholds FDA's mifepristone approval | Payers weigh GLP-1 coverage plans | 10 systems seeking pharmacy leaders

June 13, 2024 BHR Newsletter 1. Outdated software causing near misses in pharmacies: Report Full story 2. Cigna's PBM president: Weight loss drugs the 'hottest topic' right now Full story 3. BCBS Michigan to drop weight loss drug coverage Full…

CVS' high number of drug recalls | Sanders presses Novo Nordisk exec to testify | AdventHealth hospital, medicine program partner | 32 AGs demand PBM regulatory power | OHSU to end 142 employee contracts

June 12, 2024 BHR Newsletter 1. Sanders calls vote to subpoena Novo Nordisk president Full story 2. AdventHealth partners with Pharmacy of Grace Full story 3. CVS-branded drugs recalled 2x more than Walgreens, Walmart generics Full story 4. When it…

Hospital pharmacist pay grows 4% | Another potential use for Mounjaro | Average drug shortage now lasts 3+ years | Mark Cuban, grocery chain team up | Paxlovid ineffective for long COVID: Study

June 11, 2024 BHR Newsletter 1. Another potential indication for Mounjaro, Zepbound Full story 2. Paxlovid doesn't ease long COVID symptoms: Study Full story 3. Hospital pharmacist wages grow 4% Full story 4. Workforce deep dive: Health system leaders discuss…